This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM1G7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a ceiling value of $25,220.94 and an ultimate completion date of December 27, 2024.
The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not associated with any set-aside requirements. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/27/25, 9:53 AM